Transaction Details

Footnotes

The reported sale of shares was made pursuant to the Company's secondary listing on the Singapore Exchange Securities Trading Limited ("SGX-ST") on September 18, 2025. The sale was executed to facilitate initial liquidity in connection with the SGX-ST listing. The reporting person undertook the transaction in accordance with Rule 144 and applicable insider trading policies. No shares were sold on NASDAQ in connection with this transaction. | Includes (i) 2,668,057 shares held by Dr. Jiang's affiliate River Valley Ltd., (ii) 2,678,631 shares held by Red Kite LLC, each of which Dr. Jiang may be deemed to beneficially own, (iii) 837,060 shares held by Capella 2022 GRAT II, (iv) 3,338,392 shares held by the Capella 2023 GRAT, (v) 2,888,135 shares held by Capella 2024 GRAT, (vi) 1,259,578 shares held by Capella 2024 GRAT II, in case of each of (iii)-(vi), for which Dr. Jiang is the trustee and (vii) 172,000 shares held by Dr. Jiang's spouse. The Reporting Person disclaims beneficial ownership with respect to the shares held by each trust and LLC, except to the extent his pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.